CoChat

Metformin attenuates ventricular hypertrophy by activating the AMP‐activated protein kinase–endothelial nitric oxide synthase pathway in rats

Zhang, Cheng‐Xi, Pan, Si‐Nian, Meng, Rong‐Sen, Peng, Chao‐Quan, Xiong, Zhao‐Jun, Chen, Bao‐Lin, Chen, Guang‐Qin, Yao, Feng‐Juan, Chen, Yi‐Li, Ma, Yue‐Dong, Dong, Yu‐Gang · 2011 · Clinical and Experimental Pharmacology and Physiology
Cited by 91

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Summary: 1. Metformin is an activator of AMP‐activated protein kinase (AMPK). Recent studies suggest that pharmacological activation of AMPK inhibits cardiac hypertrophy. In the present study, we examined whether long‐term treatment with metformin could attenuate ventricular hypertrophy in a rat model. The potential involvement of nitric oxide (NO) in the effects of metformin was also investigated. 2. Ventricular hypertrophy was established in rats by transaortic constriction (TAC). Starting 1 week after the TAC procedure, rats were treated with metformin (300 mg/kg per day, p.o.), NG‐nitro‐l‐arginine methyl ester (l‐NAME; 50 mg/kg per day, p.o.) or both for 8 weeks prior to the assessment of haemodynamic function and cardiac hypertrophy. 3. Cultured cardiomyocytes were used to examine the effects of metformin on the AMPK–endothelial NO synthase (eNOS) pathway. Cells were exposed to angiotensin (Ang) II (10−6 mol/L) for 24 h under serum‐free conditions in the presence or absence of metformin (10−3 mol/L), compound C (10−6 mol/L), l‐NAME (10−6 mol/L) or their combination. The rate of incorporation of [3 H]‐leucine was determined, western blotting analyses of AMPK–eNOS, neuronal nitric oxide synthase (nNOS) and inducible nitric oxide synthase (iNOS) were undertaken and the concentration of NO in culture media was determined. 4. Transaortic constriction resulted in significant haemodynamic dysfunction and ventricular hypertrophy. Myocardial fibrosis was also evident. Treatment with metformin improved haemodynamic function and significantly attenuated ventricular hypertrophy. Most of the effects of metformin were abolished by concomitant l‐NAME treatment. l‐NAME on its own had no effect on haemodynamic function and ventricular hypertrophy in TAC rats. 5. In cardiomyocytes, metformin inhibited AngII‐induced protein synthesis, an effect that was suppressed by the AMPK inhibitor compound C or the eNOS inhibitor l‐NAME. The improvement in cardiac structure and function following metformin treatment was associated with enhanced phosphorylation of AMPK and eNOS and increased NO production. 6. The findings of the present study indicate that long‐term treatment with metformin could attenuate ventricular hypertrophy induced by pressure overload via activation of AMPK and a downstream signalling pathway involving eNOS–NO.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1440-1681.2010.05461.x

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 91

Metadata

Authors
Zhang, C., Pan, S., Meng, R., Peng, C., Xiong, Z., Chen, B., Chen, G., Yao, F., Chen, Y., Ma, Y., & Dong, Y.
Venue
Clinical and Experimental Pharmacology and Physiology
Publisher
Wiley
Published
2010-12-29
Volume
38
Issue
1
Pages
55-62
ISSN
  • 0305-1870 (ISSN-L)
  • 1440-1681
OpenAlex
W2127322520
Cited by
91
References
4
FWCI
0.95
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metformin attenuates ventricular hypertrophy by activating the AMP‐activated protein kinase–endothelial nitric oxide synthase pathway in rats. https://app.cochat.ai/papers/10.1111/j.1440-1681.2010.05461.x
The paper
Zhang, C., Pan, S., Meng, R., Peng, C., Xiong, Z., Chen, B., Chen, G., Yao, F., Chen, Y., Ma, Y., & Dong, Y. (2011). Metformin attenuates ventricular hypertrophy by activating the AMP‐activated protein kinase–endothelial nitric oxide synthase pathway in rats. Clinical and Experimental Pharmacology and Physiology. https://doi.org/10.1111/j.1440-1681.2010.05461.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.